AVANTI RESEARCH
LIVE

Serial Number

79413997

Owner

Croda International Plc

Attorney

Patrick J. Jennings

Filing Date

Jul 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AVANTI RESEARCH Trademark

Serial Number: 79413997 • Registration: 7895563

AVANTI RESEARCH is a trademark filed by Croda International Plc on July 23, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

Croda International Plc

Cowick Hall, Snaith

Entity Type: 84

Trademark Details

Filing Date

July 23, 2024

Registration Date

August 19, 2025

Published for Opposition

July 1, 2025

Goods & Services

Apparatus and instruments for scientific research in laboratories, namely, extruders, membranes and parts therefor

Lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labelled lipids, oxidized lipids, lipid extracts from natural sources, biological compounds conjugated with modified gold particles, fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycosphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies, active agents, additives, and excipients in pharmaceutical preparations; adjuvants, polymers and excipients, namely, surfactants, dispersants, diluents, disintegrants, emulsifiers, binders, stabilisers and fillers, all of the aforesaid being for pharmaceutical or medical use; immunostimulatory compounds for pharmaceutical or medical use; isotopes for medical use; transfection reagents for pharmaceutical or medical use; amino acids, peptides, nucleosides, nucleotides and sugars, and lipid conjugated versions of the aforesaid, all being for pharmaceutical or medical use; drug delivery auxiliary agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Chemical compounds in the nature of lipids and lipid mixtures for scientific or research use other than for medical use; lipid compounds for scientific or research use other than for medical use; adjuvants, polymers and excipients, namely, surfactants, dispersants, diluents, disintegrants, emulsifiers, binders, stabilisers and fillers, for scientific or research use other than for medical use; transfection reagents for scientific or research use other than for medical use; chemical reagents for the delivery of lipids for scientific or research use other than for medical use; standard solutions in the nature of lipids and lipid mixtures for use with analytical techniques, namely, mass spectrometry other than for medical use; lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labelled lipids, oxidized lipids, lipid extracts from natural sources, biological compounds conjugated with modified gold particles for all being for scientific or research use other than for medical use; fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycosphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies, all being for scientific or research use other than for medical use; amino acids, peptides, nucleosides, nucleotides and sugars, and lipid conjugated versions of the aforesaid, all being for scientific or research use other than for medical use; diagnostic and analytical reagents for scientific or research use other than for medical use; formulations in the nature of liposomes, pre-mixed lipid blends and lipids for bicelle formation comprising lipids for scientific or research use other than for medical use; enzymes for scientific or research use; fluorophores and fluorescent probes for scientific or research use other than for medical use; chemical auxiliary agents as raw materials for manufacturing pharmaceutical preparations, nutrient preparations, and food supplements

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 18, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 1, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 31, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 26, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 5, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 5, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 20, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 25, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 30, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2025 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 10, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 10, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 22, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 21, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 13, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 10, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 2, 2025 REPR